Heidelberg Pharma Ag operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Heidelberg Pharma Ag with three other
companies in this sector in Germany:
4Sc AG
(2018
sales of 4.17 million Euro [US$4.60 million]
),
Mologen AG
(3.05 million Euro [US$3.36 million]
of which 100%
was Goods & Services), and
Northern Bitcoin AG
(2.57 million Euro [US$2.83 million]
).
Sales Analysis.
Heidelberg Pharma Ag reported sales of 3.67 million Euro (US$4.04 million)
for the
fiscal
year ending
November of 2018.
This
represents
an
increase of 93.0%
versus 2017, when the company's sales were 1.90 million Euro.